| 000 | 01036 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515154246.0 | ||
| 264 | 0 | _c20090410 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1534-3111 | ||
| 024 | 7 |
_a10.1007/s11906-009-0014-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHermann, Matthias | |
| 245 | 0 | 0 |
_aThe hypertension peril: lessons from CETP inhibitors. _h[electronic resource] |
| 260 |
_bCurrent hypertension reports _cFeb 2009 |
||
| 300 |
_a76-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCholesterol Ester Transfer Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aQuinolines _xadverse effects |
| 700 | 1 | _aRuschitzka, Frank T | |
| 773 | 0 |
_tCurrent hypertension reports _gvol. 11 _gno. 1 _gp. 76-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11906-009-0014-9 _zAvailable from publisher's website |
| 999 |
_c18594493 _d18594493 |
||